256 related articles for article (PubMed ID: 34600331)
21. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
[TBL] [Abstract][Full Text] [Related]
22. Exploring efficacy of indole-based dual inhibitors for α-glucosidase and α-amylase enzymes: In silico, biochemical and kinetic studies.
Kawde AN; Taha M; Alansari RS; Almandil NB; Anouar EH; Uddin N; Rahim F; Chigurupati S; Nawaz M; Hayat S; Ibrahim M; Elakurthy PK; Vijayan V; Morsy M; Ibrahim H; Baig N; Khan KM
Int J Biol Macromol; 2020 Jul; 154():217-232. PubMed ID: 32173438
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in silico inhibition properties of fucoidan against α-amylase and α-D-glucosidase with relevance to type 2 diabetes mellitus.
S LS; Raghu C; H A A; P A
Carbohydr Polym; 2019 Apr; 209():350-355. PubMed ID: 30732817
[TBL] [Abstract][Full Text] [Related]
24. Rational in silico design of novel α-glucosidase inhibitory peptides and in vitro evaluation of promising candidates.
Ibrahim MA; Bester MJ; Neitz AW; Gaspar ARM
Biomed Pharmacother; 2018 Nov; 107():234-242. PubMed ID: 30096627
[TBL] [Abstract][Full Text] [Related]
25. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
[TBL] [Abstract][Full Text] [Related]
26. Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting α-glucosidase, α-amylase, and PPAR-γ: Design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus.
Thabet HK; Abusaif MS; Imran M; Helal MH; Alaqel SI; Alshehri A; Mohd AA; Ammar YA; Ragab A
Comput Biol Chem; 2024 Aug; 111():108097. PubMed ID: 38772048
[TBL] [Abstract][Full Text] [Related]
27. Discovery of novel 4,5-diphenyl-imidazol-α-aminophosphonate hybrids as promising anti-diabetic agents: Design, synthesis, in vitro, and in silico enzymatic studies.
Zareei S; Ranjbar S; Mohammadi M; Ghasemi Y; Golestanian S; Avizheh L; Moazzam A; Larijani B; Mohammadi-Khanaposhtani M; Tarahomi MM; Mahdavi M; Sadeghian N; Taslimi P
Bioorg Chem; 2023 Dec; 141():106846. PubMed ID: 37713948
[TBL] [Abstract][Full Text] [Related]
28. Spiroindolone Analogues as Potential Hypoglycemic with Dual Inhibitory Activity on α-Amylase and α-Glucosidase.
Altowyan MS; Barakat A; Al-Majid AM; Al-Ghulikah HA
Molecules; 2019 Jun; 24(12):. PubMed ID: 31242688
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of α-amylase and α-glucosidase inhibitory potential of Zea mays Linnaeus (Poaceae), Stigma maydis aqueous extract: An in vitro assessment.
Sabiu S; O'Neill FH; Ashafa AOT
J Ethnopharmacol; 2016 May; 183():1-8. PubMed ID: 26902829
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study.
Taha M; Alrashedy AS; Almandil NB; Iqbal N; Anouar EH; Nawaz M; Uddin N; Chigurupati S; Wadood A; Rahim F; Das S; Venugopal V; Nawaz F; Khan KM
Int J Biol Macromol; 2021 Nov; 190():301-318. PubMed ID: 34481854
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of alpha amylase inhibitors based on privileged indole scaffold.
Noreen T; Taha M; Imran S; Chigurupati S; Rahim F; Selvaraj M; Ismail NH; Mohammad JI; Ullah H; Javid MT; Nawaz F; Irshad M; Ali M
Bioorg Chem; 2017 Jun; 72():248-255. PubMed ID: 28482265
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors.
Toumi A; Boudriga S; Hamden K; Sobeh M; Cheurfa M; Askri M; Knorr M; Strohmann C; Brieger L
Bioorg Chem; 2021 Jan; 106():104507. PubMed ID: 33288322
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of α-glucosidase and α-amylase by herbal compounds for the treatment of type 2 diabetes: A validation of in silico reverse docking with in vitro enzyme assays.
Tolmie M; Bester MJ; Apostolides Z
J Diabetes; 2021 Oct; 13(10):779-791. PubMed ID: 33550683
[TBL] [Abstract][Full Text] [Related]
34. New Biologically Hybrid Pharmacophore Thiazolidinone-Based Indole Derivatives: Synthesis, In Vitro Αlpha-Amylase and Αlpha-Glucosidase Along with Molecular Docking Investigations.
Khan S; Iqbal S; Rahim F; Shah M; Hussain R; Alrbyawi H; Rehman W; Dera AA; Rasheed L; Somaily HH; Pashameah RA; Alzahrani E; Farouk AE
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235098
[TBL] [Abstract][Full Text] [Related]
35. In Vitro Evaluation of the Anti-Diabetic Potential of Aqueous Acetone
Akinyede KA; Oyewusi HA; Hughes GD; Ekpo OE; Oguntibeju OO
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011387
[TBL] [Abstract][Full Text] [Related]
36. Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics.
Shahzad D; Saeed A; Larik FA; Channar PA; Abbas Q; Alajmi MF; Arshad MI; Erben MF; Hassan M; Raza H; Seo SY; El-Seedi HR
Molecules; 2019 Apr; 24(8):. PubMed ID: 30999646
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of obovatol and related neolignan analogues as α-glucosidase and α-amylase inhibitors.
Sciacca C; Cardullo N; Pulvirenti L; Travagliante G; D'Urso A; D'Agata R; Peri E; Cancemi P; Cornu A; Deffieux D; Pouységu L; Quideau S; Muccilli V
Bioorg Chem; 2024 Jun; 147():107392. PubMed ID: 38723423
[TBL] [Abstract][Full Text] [Related]
38. Dihydropyridines as potential α-amylase and α-glucosidase inhibitors: Synthesis, in vitro and in silico studies.
Yousuf H; Shamim S; Khan KM; Chigurupati S; Kanwal ; Hameed S; Khan MN; Taha M; Arfeen M
Bioorg Chem; 2020 Mar; 96():103581. PubMed ID: 31978686
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study.
Hussain R; Iqbal S; Shah M; Rehman W; Khan S; Rasheed L; Rahim F; Dera AA; Kehili S; Elkaeed EB; Awwad NS; Bajaber MA; Alahmdi MI; Alrbyawi H; Alsaab HO
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234994
[TBL] [Abstract][Full Text] [Related]
40. Facile synthesis and
Punia R; Mor S; Khatri M; Kumar D; Das PP; Jindal DK; Kumar A; Selvaraj P; Kumar R; Mohil R; Jakhar K
Future Med Chem; 2024; 16(10):999-1027. PubMed ID: 38910576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
